Literature DB >> 26898194

Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project.

Anamarija M Perry1, Yvonne Perner2, Jacques Diebold3, Bharat N Nathwani4, Kenneth A MacLennan5, Hans K Müller-Hermelink6, Martin Bast7, Eugene Boilesen8, James O Armitage7, Dennis D Weisenburger4.   

Abstract

Comparative data on the distribution of non-Hodgkin lymphoma (NHL) subtypes in Southern Africa (SAF) is scarce. In this study, five expert haematopathologists classified 487 consecutive cases of NHL from SAF using the World Health Organization classification, and compared the results to North America (NA) and Western Europe (WEU). Southern Africa had a significantly lower proportion of low-grade (LG) B-NHL (34·3%) and a higher proportion of high-grade (HG) B-NHL (51·5%) compared to WEU (54·5% and 36·4%) and NA (56·1% and 34·3%). High-grade Burkitt-like lymphoma was significantly more common in SAF (8·2%) than in WEU (2·4%) and NA (2·5%), most likely due to human immunodeficiency virus infection. When SAF patients were divided by race, whites had a significantly higher frequency of LG B-NHL (60·4%) and a lower frequency of HG B-NHL (32·7%) compared to blacks (22·5% and 62·6%), whereas the other races were intermediate. Whites and other races had a significantly higher frequency of follicular lymphoma and a lower frequency of Burkitt-like lymphoma compared to blacks. The median ages of whites with LG B-NHL, HG B-NHL and T-NHL (64, 56 and 67 years) were significantly higher than those of blacks (55, 41 and 34 years). Epidemiological studies are needed to better understand these differences.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  South Africa; Southern Africa; Zimbabwe; epidemiology; non-Hodgkin lymphoma

Mesh:

Year:  2015        PMID: 26898194     DOI: 10.1111/bjh.13885

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.

Authors:  Anamarija M Perry; Jacques Diebold; Bharat N Nathwani; Kenneth A MacLennan; Hans K Müller-Hermelink; Martin Bast; Eugene Boilesen; James O Armitage; Dennis D Weisenburger
Journal:  Haematologica       Date:  2016-06-27       Impact factor: 9.941

Review 2.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

3.  Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.

Authors:  Megan J Fitzpatrick; Shahin Sayed; Zahir Moloo; Mukendi K A Kayembe; Drucilla J Roberts; Thu-Anh Pham; Liqiang Xi; Mark Raffeld; Abner Louissaint; Aliyah R Sohani
Journal:  Am J Clin Pathol       Date:  2021-06-17       Impact factor: 2.493

Review 4.  New developments in the pathology of malignant lymphoma. A review of the literature published from January-April 2016.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2016-06-13       Impact factor: 0.196

5.  Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana.

Authors:  Fallon E Chipidza; Mukendi K A Kayembe; Isaac Nkele; Jason A Efstathiou; Bruce A Chabner; Jeremy Abramson; Scott L Dryden-Peterson; Aliyah R Sohani
Journal:  JCO Glob Oncol       Date:  2021-09

6.  Extranodal lymphoma arising within the maxillary alveolus: a systematic review.

Authors:  David MacDonald; Sean Lim
Journal:  Oral Radiol       Date:  2017-12-08       Impact factor: 1.852

7.  Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.

Authors:  Antoine Jaquet; Simon P Boni; Kouakou Boidy; Judicaël Tine; Boris Tchounga; Sokhna A Touré; Jean-Jacques Koffi; Cherif Dial; Alain Monnereau; Isidore Diomande; Aristophane Tanon; Moussa Seydi; François Dabis; Saliou Diop; Gustave Koffi
Journal:  Int J Cancer       Date:  2021-06-19       Impact factor: 7.316

8.  The burden of Burkitt lymphoma in Africa.

Authors:  Lucia Hämmerl; Murielle Colombet; Rosemary Rochford; David Martin Ogwang; Donald Maxwell Parkin
Journal:  Infect Agent Cancer       Date:  2019-08-01       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.